MetaVia Inc - MTVA Company Short-Term Debt

metaviatx.com (MTVA) - corporate logo

MetaVia Inc develops advanced treatments for nervous system disorders, leveraging patent protection to drive asset value growth. The change in short-term loan amounts on the GURU.Markets time trajectory demonstrates liability dynamics, where the value of 0.00 reflects the current magnitude. The model is based on external testing under strict ownership control, while the preservation of biomaterials is ensured by specialized thermal control during transport.

MetaVia, Inc. (MTVA) - Company Current Liabilities from 11/30/2024 to 10/28/2026

Summary analytical data breakdowns for MetaVia Inc. (MTVA)

- price and consensus price forecast:
Price Chart MetaVia, Inc.|MTVA - Fair Value Consensus
- market capitalization data:
Market Value MetaVia Inc.|MTVA - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share MetaVia|MTVA - Company Net Assets|Market Capitalization to Book Value Ratio metaviatx.com|MTVA - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio MetaVia Inc|MTVA - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital MetaVia, Inc.|MTVA - Company Aggregate Debts|Debt to Book Value MetaVia Inc.|MTVA - Company Long-Term Debt|Company Short-Term Debts MetaVia
Initial company analysis:MTVA - metaviatx.com
Original product of MetaVia Inc.

The development of neurotherapy and the commercialization of AI-driven drugs require significant capital, making liquidity control critical for MetaVia Inc (MTVA). The trend in total short-term debt reflects obligations maturing within one year, allowing for an assessment of the business's ability to service debt via operating cash flow without capital degradation, which defines the risk profile of this high-tech security.

Competitors of MetaVia Inc (MTVA)

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|AXSM (Axsome Corp) - Short-Term Debt|Company Short-Term Debt ACAD|Company Current Liabilities xenon-pharma.com|Viking Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Supernus Pharmaceuticals, Inc. SUPN|Company Current Liabilities Catalyst Pharmaceuticals Inc (CPRX)|Amount of Current Liabilities Denali Corp DNLI|Harmony Biosciences - Company Short-Term Debts|biohavenpharma.com (BHVN) - Company Short-Term Debts|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Current Liabilities|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debt|PRAX: Company Short-Term Debts|Short-Term Debt Volume Anavex Life Sciences Corp|Company Short-Term Debts CBLL|Company Short-Term Debts Prothena Corporation plc PRTA|Company Current Liabilities Alector|Company Short-Term Loans and Borrowings Annexon Biosciences ANNX|Company Short-Term Debts OMER (Omeros Corp.)|NGNE: Short-Term Debt Volume|Company Short-Term Debt AC Immune|voyagertherapeutics.com (VYGR) - Company Short-Term Indebtedness|Company Short-Term Debts NMRA|Company Current Liabilities SCLX|Company Short-Term Debt TVGN (Tevogen Bio Holdings, Inc.)|Company Current Liabilities alphacognition.com ACOG|Company Current Liabilities Cognition Therapeutics, Inc. (CGTX)|IKT - Amount of Current Liabilities|SAVA - Company Current Liabilities|ASRT - Company Short-Term Debt|COYA: Company Short-Term Debts|VTGN (Vistagen) - Company Short-Term Debts|Company Short-Term Debt Ovid Therapeutics Inc (OVID)|Company Short-Term Indebtedness acumenpharm.com|CervoMed - Company Short-Term Debts|Short-Term Debt alteritytherapeutics.com ATHE|Company Current Liabilities CLNN (Clene)|PepGen Inc - Company Short-Term Debts|Company Short-Term Debt Jupiter Neurosciences (JUNS)|RLMD: Company Short-Term Loans and Borrowings|Company Short-Term Debt ANVS|GRCE (Grace Therapeutics) - Short-Term Debt|Company Short-Term Debt AIFF|Company Current Liabilities ANEW Medical, Inc.|NeuroSense Therapeutics - Company Short-Term Debts|Short-Term Debt revivapharma.com RVPH|Company Current Liabilities NeurAxis (NRXS)|Amount of Current Liabilities Helius Medical Technologies, Inc. HSDT|Passage Bio Corp - Company Short-Term Debts|Neuphoria Therapeutics Inc. (NEUP) - Company Short-Term Debts|Minerva Neurosciences (NERV) - Company Current Liabilities|athira.com (ATHA) - Company Short-Term Debt|ADXN: Company Short-Term Debts|Short-Term Debt Volume Alzamend|Company Short-Term Debts CYCN|Company Short-Term Debts protagenic.com PTIX|Company Current Liabilities Pasithea Therapeutics Corp.|Company Short-Term Loans and Borrowings Cortigent Inc CRGT|Company Short-Term Debts ATXI (Avenue Therapeutics, Inc.)|BCLI: Short-Term Debt Volume|Company Short-Term Debt Cara Therapeutics, Inc|Chromocell (CHRO) - Company Short-Term Indebtedness|Company Short-Term Debts ELYM|Company Current Liabilities ITCI|Company Short-Term Debt LBPH (Longboard Pharmaceuticals, Inc.)|Company Current Liabilities Marinus Pharmaceuticals Inc MRNS|Company Current Liabilities NKGen (NKGN)|NRBO - Amount of Current Liabilities|SAGE - Company Current Liabilities|SNPX - Company Short-Term Debt|TRVN: Company Short-Term Debts|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Debts|Company Short-Term Debt Anew Medical, Inc. (WENA)|Company Short-Term Indebtedness Cerevel Corp